No more needles? Startups are testing patches to deliver weight-loss drugs and other medications.
Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.
Nature14d
The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
AOL.co.uk15d
Wegovy obesity drug sales more than double but set to slow
Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted ... a prescription weight loss injection, surged to 19.9 billion ...
Novo doubles down on next-gen weight loss therapy despite early setback
Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite disappointing early results. Read more here.
Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...
The Independent15d
Wegovy: sales of weight loss injection more than double
Novo Nordisk's rise to become one of Europe's most ... It revealed that sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth ...
NBC Washington15d
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
Both Novo Nordisk and Eli Lilly's current weight loss treatments are administered via injection ... including its hotly anticipated experimental CagriSema treatment. Late-stage CagriSema trial ...